Results 211 to 220 of about 12,087 (255)
Some of the next articles are maybe not open access.
Urologia internationalis, 2022
Introduction: The aim of this study was to compare the efficacy of mirabegron plus tamsulosin to tamsulosin monotherapy in terms of ureteral stent-related discomfort after ureteroscopic lithotripsy.
Kai Zhang +7 more
semanticscholar +1 more source
Introduction: The aim of this study was to compare the efficacy of mirabegron plus tamsulosin to tamsulosin monotherapy in terms of ureteral stent-related discomfort after ureteroscopic lithotripsy.
Kai Zhang +7 more
semanticscholar +1 more source
Tamsulosin: Ureteral Stones [PDF]
Hospital Pharmacy, 2005 Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses.
Joyce A. Generali, Dennis J. Cada
openaire +1 more source
World Journal of Urology, 2002
This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent.
Karl-Erik Andersson +1 more
openaire +3 more sources
This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent.
Karl-Erik Andersson +1 more
openaire +3 more sources
Voltammetric investigation of Tamsulosin
Talanta, 2003The electrooxidative behavior and determination of Tamsulosin HCl (TAM), one of the alpha(1)-adrenoceptor antagonist, on a glassy carbon disc electrode were investigated for the first time by using cyclic, linear sweep, differential pulse (DPV) and square wave voltammetry (SWV). TAM showed an irreversible oxidation behavior at all pH values and buffers
Bengi Uslu +2 more
openaire +3 more sources
Tamsulosin for benign prostatic hyperplasia
Cochrane Database of Systematic Reviews, 2002Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate which can result in bothersome lower urinary tract symptoms. The treatment goal for men with BPH is to relieve these bothersome symptoms.This systematic review assessed the effects of tamsulosin in the treatment of lower urinary tract symptoms (LUTS) compatible with BPH ...
Indy Rutks +2 more
openaire +3 more sources
Biomedical chromotography, 2020
A promising combination of tamsulosin HCl and tadalafil has been recently introduced for treating two prevalent and associated urological disorders; benign prostate hyperplasia and erectile dysfunction. Novel HPTLC methods were designed and validated for
M. Tantawy +3 more
semanticscholar +1 more source
A promising combination of tamsulosin HCl and tadalafil has been recently introduced for treating two prevalent and associated urological disorders; benign prostate hyperplasia and erectile dysfunction. Novel HPTLC methods were designed and validated for
M. Tantawy +3 more
semanticscholar +1 more source
Tamsulosin for voiding dysfunction in women
International Urology and Nephrology, 2012Lower urinary tract symptoms (LUTS) affect countless individuals worldwide with an increased prevalence among those≥60 years of age. As the world's population ages, the prevalence of LUTS will continue to increase, diminishing the quality of life of many men and women. For men, alpha-1-adrenergic receptor (α1-AR) blockers are used as first-line therapy
Laura E. Meyer, Jamie N. Brown
openaire +3 more sources
Metabolism of tamsulosin in rat and dog
Xenobiotica, 19961. The metabolism of tamsulosin hydrochloride (TMS), a potent alpha 1-adrenoceptor blocking agent, was studied after a single oral administration to rat and dog. 2. Eleven metabolites (1, 2, 3, 4 and their glucuronides, sulphates of 1 and 3, and A-1) were identified from the urine and bile of rat and dog administered TMS. 3.
H. Matsushima +5 more
openaire +3 more sources
Journal of Separation Science, 2020
The advent of a new pharmaceutical formulation evokes the need for examining the chemical stability of their constituents and establishing proper stability-indicating methods. Herein, the stability of the newly co-formulated Tamsulosin and Tadalafil were
M. Rezk +3 more
semanticscholar +1 more source
The advent of a new pharmaceutical formulation evokes the need for examining the chemical stability of their constituents and establishing proper stability-indicating methods. Herein, the stability of the newly co-formulated Tamsulosin and Tadalafil were
M. Rezk +3 more
semanticscholar +1 more source
Priapism Following Ingestion of Tamsulosin
Journal of Urology, 2003While priapism has been noted rarely in patients taking -adrenergic blocking agents, including doxazosin, terazosin and prazosin, to our knowledge we report the first detailed case of priapism following ingestion of tamsulosin.1, 2 CASE REPORT A 58-year-old Hispanic male presented with painful priapism 7 hours in duration.
Scott R. Serels +2 more
openaire +3 more sources